What Is 24-hydroxycholesterol 7α-hydroxylase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 24-hydroxycholesterol 7α-hydroxylase is an enzyme encoded by the CYP7B1 gene in humans, primarily involved in cholesterol metabolism and the formation of bile acids. It catalyzes the hydroxylation of 24-hydroxycholesterol at the 7α position, a critical step in the acidic pathway of bile acid synthesis.

Key Facts

The enzyme is encoded by the CYP7B1 gene located on chromosome 8q21.3
It catalyzes the 7α-hydroxylation of 24-hydroxycholesterol, a key step in bile acid synthesis
CYP7B1 is expressed primarily in the liver, brain, and vascular endothelium
Defects in CYP7B1 are linked to hereditary spastic paraplegia type 5 (SPG5), diagnosed in rare cases since 2010
24-hydroxycholesterol 7α-hydroxylase activity helps regulate brain cholesterol elimination

Overview

24-hydroxycholesterol 7α-hydroxylase is a cytochrome P450 enzyme encoded by the CYP7B1 gene in humans. It plays a crucial role in the metabolism of cholesterol, particularly in the alternative (acidic) pathway of bile acid biosynthesis.

This enzyme specifically targets 24-hydroxycholesterol, converting it into 7α,24-dihydroxycholesterol through hydroxylation. Its activity is vital in tissues where classic bile acid synthesis is limited, such as the brain and vascular system.

Gene location: The CYP7B1 gene is located on chromosome 8q21.3, spanning approximately 7.8 kilobases with multiple exons.
Substrate specificity: It preferentially hydroxylates 24-hydroxycholesterol at the 7α position, distinguishing it from other hydroxylases like CYP7A1.
Tissue distribution: Highly expressed in the liver, but also found in the brain, prostate, and endothelial cells.
Metabolic role: Facilitates the conversion of cholesterol derivatives into chenodeoxycholic acid, a primary bile acid involved in fat digestion.
Disease link: Mutations in CYP7B1 cause SPG5, a form of hereditary spastic paraplegia, with over 50 pathogenic variants identified globally.

How It Works

The enzyme functions through a catalytic cycle involving molecular oxygen and NADPH, typical of cytochrome P450 enzymes. It modifies sterol substrates to regulate cholesterol homeostasis and neurosteroid metabolism.

Enzyme class:Cytochrome P450 (CYP) family member, part of the monooxygenase superfamily that requires heme for activity.
Catalytic reaction: Adds a hydroxyl group (–OH) to the 7α carbon of 24-hydroxycholesterol, forming 7α,24-dihydroxycholesterol.
Reaction conditions: Requires O₂ and NADPH as cofactors, with optimal activity at physiological pH (~7.4).
Kinetic values: Exhibits a Km of ~5 μM for 24-hydroxycholesterol, indicating high substrate affinity.
Regulation: Expression is suppressed by bile acids via FXR receptor feedback, unlike CYP7A1 which is regulated by SREBP.
Alternative substrates: Also metabolizes dehydroepiandrosterone (DHEA) and pregnenolone, linking it to steroid hormone regulation.

Comparison at a Glance

The following table compares 24-hydroxycholesterol 7α-hydroxylase with related enzymes in cholesterol metabolism.

Enzyme	Gene	Primary Substrate	Location	Pathway
24-hydroxycholesterol 7α-hydroxylase	CYP7B1	24-hydroxycholesterol	Liver, brain	Acidic (alternative)
Cholesterol 7α-hydroxylase	CYP7A1	Cholesterol	Liver	Classic
Oxysterol 7α-hydroxylase	CYP7B1	27-hydroxycholesterol	Liver, macrophages	Acidic
25-hydroxycholesterol 7α-hydroxylase	CYP7B1	25-hydroxycholesterol	Immune cells	Immune regulation
11β-hydroxysteroid dehydrogenase	HSD11B1	Cortisone	Adipose, liver	Steroid metabolism

This comparison highlights the specificity of CYP7B1 for multiple oxysterols, unlike CYP7A1 which initiates the classic bile acid pathway. The enzyme’s broad tissue expression suggests roles beyond hepatic metabolism, including neuroprotection and inflammation modulation. Its involvement in clearing brain-derived cholesterol underscores its importance in neurological health.

Why It Matters

Understanding 24-hydroxycholesterol 7α-hydroxylase has significant implications for treating neurodegenerative and metabolic disorders. Its role in cholesterol turnover makes it a potential therapeutic target.

Neurodegeneration: Impaired CYP7B1 function leads to cholesterol accumulation in neurons, contributing to SPG5 progression.
Therapeutic target: Enhancing its activity may help clear excess brain oxysterols in Alzheimer’s and Parkinson’s diseases.
Cardiovascular health: Regulates 27-hydroxycholesterol levels, which are linked to atherosclerosis in animal models.
Drug development: Small molecule activators of CYP7B1 are under investigation for SPG5 treatment, with preclinical trials ongoing since 2018.
Biomarker potential: Elevated 24-hydroxycholesterol in cerebrospinal fluid indicates blood-brain barrier disruption.
Evolutionary role: Conserved across mammals, suggesting a fundamental role in sterol homeostasis over 100 million years.

As research advances, 24-hydroxycholesterol 7α-hydroxylase is emerging as a key player in bridging cholesterol metabolism with neurological and systemic health, offering new avenues for diagnosis and therapy.